Session 31

Friday, April 26, 2:00 – 3:30 pm
Auditorium Léon Hirsch

Session I:
Chairs: C. Prakash Gyawali (USA), Adriana Lazarescu (Canada)

1. Wireless pH monitoring vs catheter-based pH-impedance – which is optimal to evaluate each reflux symptoms? – Daniel Sifrim (UK)
2. Is ambulatory reflux monitoring needed before anti-reflux surgery if LA grade B esophagitis is found on endoscopy? – Robert B. Yates (USA)
3. Is non-acid reflux clinically relevant and when should we look for it? – Daniela Jodorkovsy (USA)
4. SAP and SI – which symptom-reflux association metric(s) on ambulatory reflux monitoring should be used and how? – Kenneth J. Vega (USA)
5. How reliable and clinically relevant are upright vs supine and proximal reflux metrics on ambulatory reflux monitoring? – Adriana Lazarescu (Canada)
6. Does endoscopic mucosal impedance have a role in the clinical evaluation of reflux? – Marcelo F. Vela Aquino (USA)
7. When should MNBI and PSPW be routinely incorporated into reflux testing? – Edoardo V. Savarino (Italy)
8. Can pepsin be used as a reliable clinical marker for reflux? – Wai-Kit Lo (USA)
9. How should esophageal motility assessment be used in the evaluation of reflux symptoms? – Amit Patel (USA)
10. How should reflux be diagnosed in 2024? – C. Prakash Gyawali (USA)